We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Immutep and Eddingpharm Start Production of ImmuFact® IMP321

News   Apr 15, 2014

 
Immutep and Eddingpharm Start Production of ImmuFact® IMP321
 
 
 

RELATED ARTICLES

New Hope for Aggressive Breast Cancer: Diabetes Drug Creates Treatment “Sweet Spot”

News

New research funded by Breast Cancer Now has shown that a drug commonly used to treat Type 2 diabetes could make breast cancer cells susceptible to new treatments.

READ MORE

Urine Biomarkers Could Improve Diagnosis of Serious Kidney Allergic Reaction

News

A team led by Johns Hopkins Medicine researchers says it has identified two protein biomarkers in urine that may one day be used to better diagnose acute interstitial nephritis, an underdiagnosed but treatable kidney disorder that impairs renal function in the short term and can lead to chronic kidney disease, permanent damage or renal failure if left unchecked.

READ MORE

Replenishing Gut Bacteria in Mice Protects Against Food Allergies

News

After identifying altered gut microbiota in young mice with food allergies; an oral therapy was found to replenish bacteria, which also prevented food allergy and suppressed the established disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE